
AbbVie Inc.
ABBV 286.20 (0.94%) 2.68
EV: $654.32(B)
Total Equity: $-4.54(B)
Debt/Equity: 48
Dividend/share: $6.9
Div. yield: 2.42%
P/E: 49.18
Forward P/E: 20.47
P/FCF: 26.80
P/S: 7.67
P/B: N/A
EPS: $5.8
EPS (fwd): $14.0
FCF/share: $10.7
Revenue/share: $37.3
Book value/share: $-2.6
ROIC: 3.3%
ROA: 1.7%
ROE: 140.9%
Margins: Gross | Op. | Net
73.7% | 24.1% | 15.7%
0.0%of Portfolio
My holdings
Day change
Total change
Growth Estimates
Revenue
CAGR5.6%TTM
$66.01(B)
FY+1
24
3%
$67.80(B)
FY+2
25
9%
$73.94(B)
FY+3
23
8%
$79.76(B)
FY+4
15
6%
$84.44(B)
FY+5
14
3%
$86.85(B)
Net Income
CAGR28.1%TTM
$10.34(B)
FY+1
22
140%
$24.82(B)
FY+2
23
15%
$28.63(B)
FY+3
21
12%
$31.99(B)
FY+4
15
8%
$34.58(B)
FY+5
13
3%
$35.68(B)
EPS
CAGR28.5%TTM
$5.82
FY+1
27
140%
$13.98
FY+2
29
16%
$16.20
FY+3
24
11%
$18.05
FY+4
16
8%
$19.50
FY+5
15
5%
$20.40
FCF per share
CAGR12.3%TTM
$10.68
FY+1
5
11%
$11.85
FY+2
6
51%
$17.86
FY+3
6
12%
$19.97
FY+4
5
8%
$21.60
FY+5
4
12%
$19.11
